New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
13:12 EDTIBM, GOOG, CREE, AMD, ISRG, COH, DGX, MAPP, AGNOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday as the Dow was lifted by an advance in IBM (IBM) shares and the Nasdaq was similarly boosted by Google's (GOOG) outperformance. The S&P has been a laggard all morning, remaining near the flat line since the open, but is back in positive ground in afternoon trading... ECONOMIC EVENTS: In the U.S., the light economic calendar included the Home Price Index, which showed prices rose 0.6% in November, versus expectations for an increase of 0.7%. Also of note, the International Monetary Fund lowered its outlook for 2013 global output growth to 3.5% from 3.6%... COMPANY NEWS: IBM advanced over 5% at midday after its earnings report and guidance exceeded expectations. Google similarly reported earnings that beat consensus and price targets on its shares were raised all over The Street. Google advanced over 6% following the report... Among others reporting earnings last night and this morning, advancers included Cree (CREE), Advanced Micro Devices (AMD) and Intuitive Surgical (ISRG); decliners included Coach (COH) and Quest Diagnostics (DGX)... MAJOR MOVERS: Among the notable gainers not moving on earnings was MAP Pharmaceuticals (MAPP), which rose 58.6% to $24.71 after agreeing to be acquired by Allergan (AGN) for $25 per share. Allergan shares fell 1.2% following the announcement. Also lower were shares of Molycorp (MCP), which fell about 9% after disclosing it now sees Q4 and 1H13 production substantially lower than expected... INDICES: Near 1 pm ET, the Dow was up 67.87, or 0.49%, to 13,780.08; the Nasdaq was up 9.63, or 0.31%, to 3,152.81; and the S&P 500 was up 0.74, or 0.05%, to 1,493.30.
News For IBM;GOOG;CREE;AMD;ISRG;COH;DGX;MAPP;AGN From The Last 14 Days
Check below for free stories on IBM;GOOG;CREE;AMD;ISRG;COH;DGX;MAPP;AGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
August 11, 2014
07:22 EDTAGNJudge sets hearing date for Allergan suit vs. Valeant, Reuters reports
Subscribe for More Information
07:19 EDTGOOGGoogle settles suit over drug ads, to spend $250M on changes, Re/code says
Google has agreed to spend at least $50M a year for at least five years on an internal effort to make content about prescription drug abuse more visible and work with legitimate pharmacies to counter marketing by non-U.S. drug sellers as part of settlement to end shareholder lawsuits over accusations the company improperly allowed certain drug ads, reported Re/code, citing legal documents. Reference Link
06:23 EDTGOOGGoogle testing "Listen Now" music ads, WSJ reports
Subscribe for More Information
06:18 EDTCOHCitigroup comments on Coach takeover speculation
Citigroup notes Coach shares moved higher Friday amid speculation Kering could be interested in acquiring the company. Citi says Kering's stated acquisition strategy does not seem consistent with a potential takeover of Coach. Further, Citi believes Kering is unlikely to be able to finance such a large deal. It keeps a Neutral rating on Coach and a Buy rating on Kering.
06:18 EDTAMDAMD to release A68 chipsets in September, DigiTimes reports
Subscribe for More Information
05:54 EDTCOHStocks with implied volatility movement; COH TKMR
Subscribe for More Information
August 10, 2014
16:51 EDTGOOGCourt rejects $324M settlement in tech hiring conspiracy, NYT says
Subscribe for More Information
August 8, 2014
17:10 EDTCOH, AGNMarket finishes week up slightly as earnings offset by political events
Stocks finished the week fractionally higher than where they started as strong corporate earnings reports and better than expected economic data was weighed against concerns about geopolitical issues and negative M&A news. MACRO NEWS: A few ongoing geopolitical conflicts worried investors and weighed on shares. Russia unveiled sanctions against Western countries, banning the import of a wide range of food items from the U.S, the EU and a few allied countries in response to sanctions recently enacted against it from G7 nations... President Obama authorized the bombing of rebels in Iraq and Hamas and Israel failed to reach a permanent truce... An ISM services index, the U.S. trade deficit for June, and weekly jobless claims were all better than expected. Meanwhile, the increase in unit labor costs last quarter came in below the consensus outlook, perhaps easing fears that the Fed will need to raise interest rates sooner than expected. COMPANY NEWS: On the M&A front, two huge potential deals fell through as 21st Century Fox (FOX, FOXA) withdrew its offer to acquire Time Warner (TWX) and Sprint (S) reportedly decided to end its pursuit of a merger with peer T-Mobile (TMUS)... President Obama indicated that his administration would take unilateral steps in an effort to prevent companies from carrying out tax inversion acquisitions. Among the deals or possible transactions that involve inversion are Medtronic's (MDT) acquisition of Covidien (COV), Valeant's (VRX) proposed takeover of Allergan (AGN) and Mylan's (MYL) acquisition of Abbott's (ABT) developed markets branded generics pharmaceuticals business. Meanwhile, Walgreen's (WAG) stock tumbled after the U.S. company said it would not structure its takeover of European drugstore chain Alliance Boots as a tax inversion deal... 21st Century Fox, 3D printer maker Stratasys (SSYS), chip maker NVIDIA (NVDA), brewer Molson Coors (TAP), and luxury accessories maker Coach (COH) all rose following their earnings reports. Conversely, Target (TGT), luxury accessories maker Michael Kors (KORS) and Internet coupon provider Groupon (GRPN) fell following their results or guidance... Gannett (GCI) struck a deal to acquire the remaining 73% interest in Classified Ventures, whose primary asset is the online car shopping website Cars.com, for $1.8B from the other partners in the venture, which include McClatchy (MNI), Tribune Media (TRBAA), Graham Holdings (GHC) and A. H. Belo (AHC). Gannett also announced plans to spin-off its Publishing business, which includes USA Today, through a tax-free distribution to shareholders... McDonald's (MCD) stock was little changed after the company reported that its comparable store sales fell 2.5% in July, which was significantly worse than expected. Food quality issues weighed on the fast food company's sales in Asia and as a result of the China supplier issue, the company warned its previously issued global comparable sales forecast for 2014 is now at risk. INDEXES: The Dow finished the week up 0.35% to 16,553.93, the S&P 500 rose 0.32% to 1,931.59, and the Nasdaq gained 0.41% to 4,370.90.
16:16 EDTGOOGU.S. judge rejects Apple, Google antitrust hiring accord, Bloomberg reports
Subscribe for More Information
12:08 EDTGOOGUpcoming Google tablet may feature 8 MP rear camera, PhoneArena says
Google's upcoming Nexus 8 tablet will feature an 8 MP rear camera, a 64 bit Tegra processor, 4 GB of memory, and the Android L operating system, without any HTC Sense overlay, according to PhoneArena, which cited various leaks and comments from an IHS analyst. Reference Link U
11:23 EDTCOHCoach tests top of recent trading range, levels to watch
Subscribe for More Information
10:58 EDTAGNAllergan rises after analyst sees compelling risk/reward, upgrades stock
Shares of drug maker Allergan (AGN) are rising after research firm Leerink Swann upgraded the stock in a note to investors today. WHAT'S NEW: After Allergan's stock fell recently, the shares' risk/reward ratio has become "increasingly positive" and is now compelling, Leerink analyst Seamus Fernandez wrote. Allergan's business has shown little if any weakness as a result of Valeant's (VRX) takeover bid for the company and Allergan's planned restructuring is overdue, the analyst contended. The weakness in Allergan's shares has been caused mainly by technical and arbitrage issues, according to Fernandez, who forecasts that the company can generate EPS of over $8.20 next year. Meanwhile, Valeant's bid will prevent Allergan's stock from dropping too far as long as it is on the table, Fernandez believes. Allergan has a number of other upcoming potential positive catalysts, including a potential $5B-$10B share repurchase initiative and data due to be released on August 12 on DARPin, the company's drug for wet age-related macular degeneration. A potential compelling acquisition by Allergan could also boost the stock, the analyst wrote. He upgraded the stock to Outperform from Market Perform and placed a $184 price target on the shares. PRICE ACTION: In mid-morning trading, Allergan rose $3.98, or 2.6%, to $155.67.
10:27 EDTCOHCoach August calls active
Subscribe for More Information
10:24 EDTCOHRumor: Coach strength attributed to takeover speculation
Subscribe for More Information
10:00 EDTAGNOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Activision Blizzard (ATVI) upgraded to Buy from Neutral at Longbow... Allergan (AGN) upgraded to Outperform from Market Perform at Leerink... Andersons (ANDE) upgraded to Buy from Hold at Feltl... Arista Networks (ANET) upgraded to Buy from Neutral at Citigroup... Barrick Gold (ABX) upgraded to Conviction Buy from Buy at Goldman... Brinker (EAT) upgraded to Outperform from Market Perform at Raymond James... CF Industries (CF) upgraded to Buy from Hold at Feltl... CST Brands (CST) upgraded to Neutral from Underperform at Credit Suisse... Cimarex Energy (XEC) upgraded to Accumulate from Hold at KLR Group... Coca-Cola HBC (OCCH) upgraded to Buy from Hold at Deutsche Bank... Delek US (DK) upgraded to Outperform at Cowen... Fifth Street Finance (FSC) upgraded to Buy from Neutral at Guggenheim... Glimcher Realty Trust (GRT) upgraded to Buy from Neutral at BofA/Merrill... Goodrich Petroleum (GDP) upgraded to Strong Buy from Outperform at Raymond James... Monster Beverage (MNST) upgraded to Neutral from Underperform at Longbow... NIC Inc. (EGOV) upgraded to Outperform from Market Perform at Barrington... NVIDIA (NVDA) upgraded at Needham... POZEN (POZN) upgraded to Buy from Hold at Ascendiant... Power Solutions (PSIX) upgraded to Accumulate from Neutral at Global Hunter... Primoris (PRIM) upgraded to Buy from Hold at BB&T... Sierra Bancorp (BSRR) upgraded to Outperform from Market Perform at Raymond James... Sonus Networks (SONS) upgraded to Outperform from Market Perform at Barrington... Stone Energy (SGY) upgraded to Buy from Accumulate at KLR Group... Tornier (TRNX) upgraded at BMO Capital... Tyson Foods (TSN) upgraded to Buy from Hold at BB&T... WGL Holdings (WGL) upgraded to Buy from Hold at Brean Capital.
07:01 EDTAGNHarvard professor says Treasury can reduce inversion incentives, NY Times says
Subscribe for More Information
06:44 EDTIBMNew IBM chip identifies patterns, NY Times says
IBM has developed a new type of computer chip that tries to imitate the pattern identifying powers of human brains, according to The New York Times. The chip could eventually perform calculations that today's supercomputers are not capable of, the newspaper added. Reference Link
06:37 EDTGOOGMotorola to be sales arm for Lenovo to increase global shipments, DigiTimes says
Subscribe for More Information
06:16 EDTAGNAllergan upgraded to Outperform from Market Perform at Leerink
Leerink upgraded its rating on Allergan (AGN) shares to Outperform citing a compelling risk/reward profile following the recent pullback in shares. The firm believes Valeant's (VRX) takeover attempt is having little if any impact on Allergan's business. Leerink has a $184 price target for Allergan shares, which closed yesterday down $5.18 to $151.92.
06:01 EDTGOOGYahoo to strengthen email encryption for users, Mashable reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use